^
Association details:
Biomarker:No biomarker
Cancer:Burkitt Lymphoma
Regimen:R-GDP (cisplatin + dexamethasone injection + gemcitabine + Rituxan (rituximab))
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Burkitt lymphoma: suggested treatment regimens…second-line therapy…useful in certain circumstances…RGDP (rituximab, gemcitabine, dexamethasone, cisplatin)